SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-21-012468
Filing Date
2021-06-17
Accepted
2021-06-17 16:37:53
Documents
1
Period of Report
2021-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_162396220640564.html 3  
1 FORM 3 wf-form3_162396220640564.xml 3 1688
  Complete submission text file 0001628280-21-012468.txt   3036
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address #1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8
Business Address
Balakrishnan Brinda (Reporting) CIK: 0001868236 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36421 | Film No.: 211025222